Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia
- 30 September 2000
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 14 (3) , 121-129
- https://doi.org/10.1054/blre.2000.0132
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Cytogenetic Evidence for Splenic Origin of Blastic Transformation in Chronic Myeloid LeukaemiaScandinavian Journal of Haematology, 2009
- Splenic function in chronic myelogenous leukemiaEuropean Journal of Haematology, 2009
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Treatment of agnogenic myeloid metaplasia with danazol: A report of four casesAmerican Journal of Hematology, 1996
- Plasma soluble interleukin‐2 receptor in patients with primary myelofibrosisBritish Journal of Haematology, 1994
- The spleen and pooling of blood cellsEuropean Journal of Haematology, 1988
- Chromosome changes and splenectomy in Ph1-positive chronic myeloid leukemia: I. Predictive parameters in the blastic phaseCancer, 1984
- Results of a prospective randomized trial of early splenectomy in chronic myeloid leukemia. The italian cooperative study group on chronic myeloid leukemiaCancer, 1984
- Removal of abnormal clone of leukaemic cells by splenectomy.BMJ, 1975
- Chronic Granulocytic Leukaemia: Effect of Elective Splenectomy on the Course of DiseaseBMJ, 1975